Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Recruiting now · Phase 4

Conditions studied: HPV Infection, CIN 2/3, Cervical Cancer

In brief

The study aims to evaluate whether organised, concomitant HPV vaccination and HPV screening offered to all resident women aged 22-27 will result in a more rapid elimination of HPV infection in Sweden. This objective will be examined at the population level.

Key facts

Study ID
NCT04910802
Run by
Miriam Elfström
People needed
150000
Starts
2021-05-03
Expected to finish
2027-12-31
Last updated by the study team
2021-09-16

Who can join

Age: 22 and older, up to 27. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.